tm logo
HAMPLATIN
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 13 Oct 2023

Last Applicant/ Owned by

No. 229 Guyuan Rd.

Changsha, Hunan

CN

Serial Number

86480624 filed on 15th Dec 2014

Registration Number

5171990 registered on 28th Mar 2017

in the Principal Register

Correspondent Address

Timothy T. Wang

TIMOTHY T. WANG

8140 Walnut Hill Ln Ste 500

Dallas, TX 75231

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

HAMPLATIN

Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological res Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design


First Use Date in General

10th May 2016

First Use Date in Commerce

10th May 2016

Class [005]
Pharmaceutical Products


Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes


First Use Date in General

10th May 2016

First Use Date in Commerce

10th May 2016

Mark Details


Serial Number

No 86480624

Mark Type

No Service Mark

Attorney Docket Number

No ACIP0124

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Oct 2023CANCELLED SEC. 8 (6-YR)
28th Mar 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28th Mar 2017REGISTERED-PRINCIPAL REGISTER
22nd Feb 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Feb 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Feb 2017STATEMENT OF USE PROCESSING COMPLETE
11th Feb 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
25th Jan 2017TEAS STATEMENT OF USE RECEIVED
25th Jan 2017USE AMENDMENT FILED
02th Aug 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT